Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa

Prolyl-endopeptidase supplementation has been proposed to favour gliadin degradation as an alternative treatment for coeliac disease (CD), although the real usefulness of this therapy in vivo is still under discussion. 1 However, our data point to alternative treatments aiming to modify the intestin...

Descripción completa

Detalles Bibliográficos
Autores: Bernardo Ordiz, David, Garrote Adrados, José Antonio, Nadal, I., León, Alberto José, Calvo Romero, María Del Carmen, Fernández Salazar, Luis Ignacio, Blanco Quiros, Alfredo, Sanz, Y., Arranz Sanz, Eduardo
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2009
País:España
Institución:Universidad de Valladolid
Repositorio:UVaDOC. Repositorio Documental de la Universidad de Valladolid
OAI Identifier:oai:uvadoc.uva.es:10324/4436
Acceso en línea:https://doi.org/10.1136/gut.2008.167296
http://uvadoc.uva.es/handle/10324/4436
Access Level:acceso abierto
Palabra clave:Enfermedad celíaca
Gliadina
Intestinos - Enfermedades
id ES_a31d13e5c8a5aed51a52f89cc75b5147
oai_identifier_str oai:uvadoc.uva.es:10324/4436
network_acronym_str ES
network_name_str España
spelling Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa Bernardo Ordiz, David Garrote Adrados, José Antonio Nadal, I. León, Alberto José Calvo Romero, María Del Carmen Fernández Salazar, Luis Ignacio Blanco Quiros, Alfredo Sanz, Y. Arranz Sanz, Eduardo Enfermedad celíaca Gliadina Intestinos - Enfermedades Prolyl-endopeptidase supplementation has been proposed to favour gliadin degradation as an alternative treatment for coeliac disease (CD), although the real usefulness of this therapy in vivo is still under discussion. 1 However, our data point to alternative treatments aiming to modify the intestinal microbiota in patients with CD by the use of probiotics and/or prebiotics. We propose that the induction of gliadin proteolysis in the human gut might not be the solution but the origin of CD. BMJ https://doi.org/10.1136/gut.2008.167296 http://uvadoc.uva.es/handle/10324/4436
title Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa
spellingShingle Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa
Bernardo Ordiz, David
Enfermedad celíaca
Gliadina
Intestinos - Enfermedades
title_short Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa
title_full Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa
title_fullStr Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa
title_full_unstemmed Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa
title_sort Is it true coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa
author Bernardo Ordiz, David
author_facet Bernardo Ordiz, David
Garrote Adrados, José Antonio
Nadal, I.
León, Alberto José
Calvo Romero, María Del Carmen
Fernández Salazar, Luis Ignacio
Blanco Quiros, Alfredo
Sanz, Y.
Arranz Sanz, Eduardo
author_role author
author2 Garrote Adrados, José Antonio
Nadal, I.
León, Alberto José
Calvo Romero, María Del Carmen
Fernández Salazar, Luis Ignacio
Blanco Quiros, Alfredo
Sanz, Y.
Arranz Sanz, Eduardo
author2_role author
author
author
author
author
author
author
author
topic Enfermedad celíaca
Gliadina
Intestinos - Enfermedades
topic_facet Enfermedad celíaca
Gliadina
Intestinos - Enfermedades
description Prolyl-endopeptidase supplementation has been proposed to favour gliadin degradation as an alternative treatment for coeliac disease (CD), although the real usefulness of this therapy in vivo is still under discussion. 1 However, our data point to alternative treatments aiming to modify the intestinal microbiota in patients with CD by the use of probiotics and/or prebiotics. We propose that the induction of gliadin proteolysis in the human gut might not be the solution but the origin of CD.
publishDate 2009
format article
status_str acceptedVersion
url https://doi.org/10.1136/gut.2008.167296
http://uvadoc.uva.es/handle/10324/4436
eu_rights_str_mv openAccess
publisher BMJ
institution Universidad de Valladolid
collection UVaDOC. Repositorio Documental de la Universidad de Valladolid
reponame_str UVaDOC. Repositorio Documental de la Universidad de Valladolid
instname_str Universidad de Valladolid
_version_ 1878438750571200512
publishDateSort 2009
author_browse Arranz Sanz, Eduardo
Bernardo Ordiz, David
Blanco Quiros, Alfredo
Calvo Romero, María Del Carmen
Fernández Salazar, Luis Ignacio
Garrote Adrados, José Antonio
León, Alberto José
Nadal, I.
Sanz, Y.
publisherStr BMJ
score 6,9303427